SFT — Sopharma Trading AD Income Statement
0.000.00%
Last trade - 00:00
- BGN202.23m
- BGN408.71m
- BGN1.68bn
- 64
- 96
- 57
- 86
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 959 | 1,165 | 1,344 | 1,487 | 1,681 |
Cost of Revenue | |||||
Gross Profit | 938 | 1,145 | 1,319 | 1,460 | 1,648 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 947 | 1,148 | 1,330 | 1,469 | 1,636 |
Operating Profit | 11.7 | 17.7 | 13.8 | 18.3 | 44.6 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 10.3 | 13.9 | 9.44 | 12.4 | 34.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | 8.92 | 11.5 | 8.05 | 9.08 | 29.2 |
Net Income Before Extraordinary Items | |||||
Net Income | 8.92 | 11.5 | 8.05 | 9.08 | 29.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 8.92 | 11.5 | 8.05 | 9.08 | 29.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 22 | 25.5 | 29.7 | 28.5 | 37.5 |
Dividends per Share |